Diagnostic Value of Soluble Form of Mer Tyrosine Kinase (sMerTK)‎ in Tuberculous Pleural Effusion and Malignant Pleural Effusion

Abstract EN

Objectives.

With the development of proteomics, it has been indicated that differentially expressed proteins are biological markers for the diagnosis of different types of pleural effusion (PE).

The aim of our study was to explore the value of sMerTK (soluble form of Mer tyrosine kinase) in the differential diagnosis of tuberculous pleural effusion (TPE) and malignant pleural effusion (MPE).

In addition, we also wanted to explore whether MerTK was associated with IL-1β and TNF-α, which are inflammatory factors related to pleural effusion.

Methods.

We screened all patients who underwent thoracoscopy and had a definite diagnosis.

In total, 136 patients were enrolled in this study and classified into two groups, with 64 patients in the TPE group and 72 patients in the MPE group.

The concentrations of sMerTK in the TPE and MPE groups were detected by ELISA.

The diagnostic accuracy was determined by generating receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC).

Correlations between the expression level of sMerTK and those of the inflammatory factors interleukin 1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) were also studied using Pearson’s linear correlation analysis.

Results.

The concentrations of sMerTK were 5,278.77±2,479.98 ng/L and 859.91±540.45 ng/L in the TPE and MPE groups, respectively.

The concentration of sMerTK in TPE was shown to be significantly higher than that in MPE (P<0.05).

The area under the ROC curve for sMerTK in distinguishing TPE from MPE was 0.958, with a cutoff value of 2,122 ng/L.

The sensitivity and specificity for sMerTK were 98.61% and 90.63% (P<0.05).

The expression levels of sMerTK in these two groups were not correlated with those of the inflammatory factors IL-1β and TNF-α (P>0.05).

Conclusions.

The expression level of sMerTK in PE could be a potential biomarker for common use in the diagnosis of TPE and MPE.